Brought to you by 
TiGenix buys Orthomimetics in stock swap
21 Jan 2010
Executive Summary
In an effort to become a leading regenerative medicine play, TiGenix is acquiring privately held orthopedics company Orthomimetics in a stock swap worth €16.2mm ($24.3mm). TiGenix is issuing Orthomimetics 3.7mm shares valued at €4.40 each.
Deal Industry
- Biotechnology
- Medical Devices
-
Medical Devices
- Biomaterials
- Implantable Devices
-
Surgical Equipment & Devices
- Minimally or Less Invasive
Deal Status
- Final
Deal Type
-
Acquisition
- Acquisition of Private Biotech
- Full Acquisition
- Intra-Biotech Deal
- Payment Includes Stock
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
TiGenix buys Orthomimetics in stock swap
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice